OrbiMed Capital GP VI LLC insider trades
OrbiMed Capital GP VI LLC has filed 15 Form 4s with the SEC that we hold, for Disc Medicine, Inc. (IRON) (Director), NeuroPace Inc (NPCE) (10% owner), Edgewise Therapeutics, Inc. (EWTX) (Director, 10% owner) and ImageneBio, Inc. (IKNA) (Director), among 9 companies in all. Across all of them we count 9 purchases worth $12.2M and 39 sales worth $173.7M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 3,284,800 shares of VRNA worth $71.3M, dated 2022-12-22. The first filing on our record is dated 2022-05-20 and the latest 2025-04-11.
Disc Medicine, Inc. (IRON)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-03-10 | S, sale reported on Form 4 | 53 | $2.9K | 2025-03-12 |
| 2025-03-10 | S, sale reported on Form 4 | 211 | $11.6K | 2025-03-12 |
| 2025-03-10 | S, sale reported on Form 4 | 136 | $7.5K | 2025-03-12 |
| 2025-03-10 | S, sale reported on Form 4 | 26,596 | $1.4M | 2025-03-12 |
| 2025-03-10 | S, sale reported on Form 4 | 106,384 | $5.8M | 2025-03-12 |
| 2025-03-10 | S, sale reported on Form 4 | 68,766 | $3.7M | 2025-03-12 |
| 2025-03-11 | S, sale reported on Form 4 | 3,567 | $192.7K | 2025-03-12 |
| 2025-03-11 | S, sale reported on Form 4 | 14,267 | $770.6K | 2025-03-12 |
| 2025-03-11 | S, sale reported on Form 4 | 9,222 | $498.1K | 2025-03-12 |
| 2025-03-12 | S, sale reported on Form 4 | 27,750 | $1.5M | 2025-03-12 |
| 2025-03-12 | S, sale reported on Form 4 | 42,930 | $2.3M | 2025-03-12 |
| 2025-03-12 | S, sale reported on Form 4 | 233 | $12.8K | 2025-03-12 |
| 2025-03-12 | S, sale reported on Form 4 | 933 | $51.4K | 2025-03-12 |
| 2025-03-12 | S, sale reported on Form 4 | 603 | $33.2K | 2025-03-12 |
| 2025-03-12 | S, sale reported on Form 4 | 10,733 | $584.3K | 2025-03-12 |
| 2025-03-19 | S, sale reported on Form 4 | 13,517 | $730.2K | 2025-03-21 |
| 2025-03-19 | S, sale reported on Form 4 | 20,911 | $1.1M | 2025-03-21 |
| 2025-03-19 | S, sale reported on Form 4 | 5,228 | $282.4K | 2025-03-21 |
| 2025-03-20 | S, sale reported on Form 4 | 941 | $50.8K | 2025-03-21 |
| 2025-03-20 | S, sale reported on Form 4 | 1,457 | $78.7K | 2025-03-21 |
| 2025-03-20 | S, sale reported on Form 4 | 364 | $19.7K | 2025-03-21 |
| 2025-03-21 | S, sale reported on Form 4 | 3,412 | $184.2K | 2025-03-21 |
| 2025-03-21 | S, sale reported on Form 4 | 5,279 | $285.1K | 2025-03-21 |
| 2025-03-21 | S, sale reported on Form 4 | 1,320 | $71.3K | 2025-03-21 |
NeuroPace Inc (NPCE)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-10-02 | S, sale reported on Form 4 | 7,614 | $69.1K | 2023-10-04 |
| 2023-10-03 | S, sale reported on Form 4 | 700 | $6.3K | 2023-10-04 |
| 2024-04-11 | S, sale reported on Form 4 | 461,899 | $6.7M | 2024-04-15 |
| 2024-04-12 | S, sale reported on Form 4 | 23,101 | $333.1K | 2024-04-15 |
| 2024-04-16 | S, sale reported on Form 4 | 14,069 | $197.1K | 2024-04-18 |
| 2024-04-17 | S, sale reported on Form 4 | 300 | $4.2K | 2024-04-18 |
| 2024-04-18 | S, sale reported on Form 4 | 2,623 | $36.9K | 2024-04-18 |
Edgewise Therapeutics, Inc. (EWTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-05-18 | P, purchase reported on Form 4 | 138,000 | $995.0K | 2022-05-20 |
| 2024-01-23 | P, purchase reported on Form 4 | 454,545 | $5.0M | 2024-01-25 |
ImageneBio, Inc. (IKNA)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-06-22 | P, purchase reported on Form 4 | 66,806 | $237.2K | 2022-06-24 |
| 2022-06-23 | P, purchase reported on Form 4 | 23,419 | $86.9K | 2022-06-24 |
| 2022-06-24 | P, purchase reported on Form 4 | 65,965 | $288.3K | 2022-06-24 |
| 2022-06-24 | P, purchase reported on Form 4 | 96,035 | $515.7K | 2022-06-24 |
ARS Pharmaceuticals, Inc. (SPRY)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-29 | P, purchase reported on Form 4 | 500,000 | $3.1M | 2023-08-31 |
Compass Therapeutics, Inc. (CMPX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-04-09 | S, sale reported on Form 4 | 3,571,428 | $5.7M | 2025-04-11 |
SCPH
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-08-13 | P, purchase reported on Form 4 | 21,658 | $86.6K | 2024-08-15 |
| 2024-08-13 | P, purchase reported on Form 4 | 478,342 | $1.9M | 2024-08-15 |
SWTX
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-09-12 | S, sale reported on Form 4 | 30,000 | $959.4K | 2022-09-14 |
| 2022-09-12 | S, sale reported on Form 4 | 123,897 | $4.0M | 2022-09-14 |
VRNA
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-12-22 | S, sale reported on Form 4 | 3,284,800 | $71.3M | 2022-12-27 |
| 2022-12-22 | S, sale reported on Form 4 | 684,696 | $15.1M | 2022-12-27 |
| 2022-12-23 | S, sale reported on Form 4 | 92,992 | $2.2M | 2022-12-27 |
| 2022-12-23 | S, sale reported on Form 4 | 1,116,048 | $25.9M | 2022-12-27 |
| 2022-12-23 | S, sale reported on Form 4 | 961,328 | $21.4M | 2022-12-27 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1682115) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms